Pancreatic Cancer Research

ResearcherDuke UniversityActive in the last 2 years

Dimitrios Moris

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5276-0699; OpenAlex author ID A5072293972, A5123103816. Sources: OpenAlex.

Their work

Papers
15 (first author 5, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 3 papers · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 15

  1. Treatment Sequencing and Survival in Octogenarians With Pancreatic Ductal Adenocarcinoma: A SEER Analysis. Last author DOI 10.1177/00031348261429442↗
  2. Recovery to Intended Oncologic Therapy After Upfront Pancreatectomy for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1177/00031348261502308↗
  3. Vascular Resection, Reconstruction, and Divestment in Pancreatoduodenectomy: Expanding Boundaries in Pancreatic Cancer Surgery. Co-author DOI 10.3390/cancers18040577↗
  4. The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.843769↗
  5. Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review. First author DOI 10.1001/jamasurg.2021.0149↗
  6. The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis. Co-author DOI 10.1007/s00268-020-05821-7↗
  7. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC). Co-author DOI 10.1097/coc.0000000000000826↗
  8. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. First author DOI 10.3390/cancers13051071↗
  9. The efficacy and safety of the open approach irreversible electroporation in the treatment of pancreatic cancer: A systematic review. First author DOI 10.1016/j.ejso.2020.05.017↗
  10. New NCCN Guidelines for Locally Advanced Pancreatic Cancer: New Horizons in Extending Resectability. Last author PMID 33099964↗
  11. Initial experience with neoadjuvant FOLFIRINOX as first line therapy for locally advanced pancreatic cancer. Co-author PMID 33277879↗
  12. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07261-7↗
  13. ASO Author Reflections: Irreversible Electroporation for Locally Advanced Pancreatic Cancer. First author DOI 10.1245/s10434-019-07436-2↗
  14. Exosomes in Pancreatic Cancer: from Early Detection to Treatment. Co-author DOI 10.1007/s11605-018-3693-1↗
  15. Ablation of the locally advanced pancreatic cancer: An introduction and brief summary of techniques. First author PMID 27569086↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Timothy Michael Pawlik · 4 shared papers, 2018–2021 · strength 0.50
  2. Gupta Pk · 1 shared paper, 2026 · strength 0.50
  3. Athanasios S. Petrou · 4 shared papers, 2016–2021 · strength 0.45
  4. Andrew S. Barbas · 2 shared papers, 2021–2022 · strength 0.45
  5. Georgia Sofia Karachaliou · 3 shared papers, 2020 · strength 0.44
  6. Nikolaos Dimitrokallis · 3 shared papers, 2020–2021 · strength 0.43
  7. Diamantis I. Tsilimigras · 3 shared papers, 2019–2020 · strength 0.38
  8. Dimitrios Giannis · 2 shared papers, 2020–2021 · strength 0.36
  9. Evangelos S. Felekouras · 3 shared papers, 2019–2021 · strength 0.35
  10. Yuri Genyk · 1 shared paper, 2026 · strength 0.32
  11. Keith Robert Unger · 1 shared paper, 2026 · strength 0.32
  12. Benjamin Adam Weinberg · 1 shared paper, 2026 · strength 0.32
  13. Emily R. Winslow · 1 shared paper, 2026 · strength 0.30
  14. Dimitriοs Schizas · 2 shared papers, 2021 · strength 0.25
  15. Dimitrios Oikonomou · 2 shared papers, 2020–2021 · strength 0.24
  16. Alexandros Papalampros · 2 shared papers, 2020–2021 · strength 0.24
  17. Argyrios Gyftopoulos · 1 shared paper, 2022 · strength 0.22
  18. Ioannis A. Ziogas · 1 shared paper, 2022 · strength 0.22
  19. Matthew H. G. Katz · 1 shared paper, 2021 · strength 0.16
  20. Eileen Mary O'Reilly · 1 shared paper, 2021 · strength 0.16
  21. Michail N. Mavros · 1 shared paper, 2021 · strength 0.16
  22. Paul Jack Karanicolas · 1 shared paper, 2021 · strength 0.16
  23. Konstantinos P. Toutouzas · 1 shared paper, 2021 · strength 0.13
  24. Demetris Papamichael · 1 shared paper, 2021 · strength 0.12
  25. Michalis V. Karamouzis · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.